Status report on hypertension in Africa - Consultative review for the 6th Session of the African Union Conference of Ministers of Health on NCD's

Pan African Medical Journal

Volumn 16, Issue , 2013, Pages

  van de Vijver, Steven ^a,b   Akinyi, Hilda ^a   Oti, Samuel ^a,b   Olajide, Ademola ^c   Agyemang, Charles ^d   Aboderin, Isabella ^a   Kyobutungi, Catherine ^a  

^a AFRICAN POPULATION AND HEALTH RESEARCH CENTER   (Kenya)

^b AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

^c African Union Commission   (Ethiopia)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Africa; Cardiovascular diseases; Control; Hypertension; Risk factor; Treatment

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AFRICA; AGING; ALCOHOL CONSUMPTION; ARTICLE; AWARENESS; CHRONIC DISEASE; COST BENEFIT ANALYSIS; COST OF ILLNESS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DISEASE CONTROL; DISEASE SURVEILLANCE; DRUG EFFECT; ENVIRONMENTAL FACTOR; EPIDEMIC; FRUIT; HUMAN; HYPERTENSION; LIFESTYLE; OBESITY; PHYSICAL ACTIVITY; POPULATION RISK; PRACTICE GUIDELINE; PRIMARY PREVENTION; PUBLIC HEALTH PROBLEM; REHABILITATION CARE; RISK FACTOR; SALT INTAKE; SECONDARY PREVENTION; TOBACCO; TREATMENT PLANNING; URBANIZATION; VEGETABLE;

EID: 84886255410     PISSN: 19378688     EISSN: None     Source Type: Journal    
DOI: 10.11604/pamj.2013.16.38.3100     Document Type: Article

References (72)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012;380(9859):2095-128.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005 Jan 15-21;365(9455):217-23.
3. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990?2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012;380(9859):2224-60.
4. Beaglehole R, Epping-Jordan J, Patel V, Chopra M, Ebrahim S, Kidd M, et al. Improving the prevention and management of chronic disease in low-income and middle income countries: A priority for primary health care. Lancet. 2008;372:940-9.
5. Fuentes R, Ilmaniemi N, Laurakainen E, Tuomilehto J, Nissinen A. Hypertension in developing economies: A review of population-based studies carried out from 1980 to 1998. J Hypertens. 2000 May;18(5):521-9.
6. Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet. 2012 Aug 11;380(9841):611-9.
7. Seedat YK. Hypertension in developing nations in sub-Saharan Africa. Journal of human hypertension. 2000;10-11(14):739-4.
8. Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation. 2005 Dec 6;112(23):3562-8.
9. Lopez A, Mathers C, Ezzati M, al e. Global burden of disease and risk factors. Washington, DC: Oxford University Press and World Bank, 2006. r
10. Bygbjerg IC. Double burden of noncommunicable and infectious diseases in developing countries. Science. 2012 Sep 21;337(6101):1499-501.
11. Addo J, Smeeth L, Leon DA. Hypertension in sub-saharan Africa: a systematic review. Hypertension. 2007 Dec;50(6):1012-8.
12. Imperial, College, London. Global Burden of Metabolic Risk Factors of Chronic Diseases [cited 2013 29 January]. Available from: http://www.imperial.ac.uk/medicine/globalmetabolics/. Accessed 5th February 2013.
13. Walker RW, McLarty DG, Kitange HM, Whiting D, Masuki G, Mtasiwa DM. Stroke mortality in urban and rural Tanzania. Adult morbidity and mortality project. Lancet. 2000 May 13;355(9216):1684-7.
14. Mensah AG. Epidemiology of stroke and high blood pressure in Africa. Heart. 2008 Jun;94(6):697-705.
15. Omran A. The Epidemiologic Transition: A Theory of the Epidemiology of Population Change. The Milbank Memorial Fund Quarterly. 1971;49(4):509-38.
16. The continuing epidemiological transition in sub-Saharan Africa: A workshop summary2012; Washington DC: The national academies press. r
17. Mbewu A, Jean-Claude M. Cardiovascular disease. In: Jamieson DT, Richard TF, Malegapuru WM, Eduard RB, Florence KB, Karen JH, et al., editors. Disease and morbidity in sub-Saharan Africa. Washington, DC: The International Bank for Reconstruction and Development/The World Bank; 2006. p. 305-29.
18. Dodu SR. Emergence of cardiovascular diseases in developing countries. Cardiology. 1988;75(1):56-64.
19. Nissinen A, Bothig S, Granroth H, Lopez AD. Hypertension in developing countries. World Health Stat Q. 1988;41(3-4):141-54.
20. Agyemang C. Rural and urban differences in blood pressure and hypertension in Ghana, West Africa. Public health. 2006;120(6):525-33.
21. Poulter NR, Khaw KT, Hopwood BE, et al. The Kenyan Luo migration study: Observations on the initiation of a rise in blood pressure. BMJ. 1990 Apr 14;300(6730):967-72.
22. UN-Habitat. The State of African Cities 2010: Governance, Inequalities and Urban Land Markets. Nairobi: UN-Habitat, 2010. r
23. Agyemang C, Bruijnzeels MA, Owusu-Dabo E. Factors associated with hypertension awareness, treatment, and control in Ghana, West Africa. J Hum Hypertens. 2005;20(1):67-71.
24. Damasceno A, Azevedo A, Silva-Matos C, Prista A, et al. Hypertension prevalence, awareness, treatment, and control in mozambique: urban/rural gap during epidemiological transition. Hypertension. 2009 Jul;54(1):77-83.
25. Godfrey R, Julien M. Urbanisation and health. Clinical Medicine, Journal of the Royal College of Physicians. 2005;5(2):137-41.
26. Aboderin I. Africa is ageing? but how prepared is the continent? Business Day Live. 2012. r
27. Institute of Medicine. Promoting Cardiovascular Health in the Developing World. Fuster V, Kelly B, editors. Washington: The National Academies Press; 2001.
28. World Health Organization. STEPwise approach to chronic disease risk factor surveillance (STEPS)2008 23-03-2012. Available from: http://www.who.int/chp/steps/riskfactor/en/index.html. Accessed 5th February 2013.
29. WHO. Cardiovascular diseases in the African region: current situation and perspectives. 2005. http://www.afro.who.int/rc55/documents/afr_rc55_12_cardiovascular.pdf. Accessed 5th February 2013.
30. Twagirumukiza M, De Bacquer D, Kips JG, de Backer G, et al. Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: an estimate from population studies. J Hypertens. 2011 Jul;29(7):1243-52.
31. Hendriks ME, Wit FWNM, Roos MTL, Brewster LM, et al. Hypertension in Sub-Saharan Africa: Cross-Sectional Surveys in Four Rural and Urban Communities. PLoS ONE. 2012;7(3):e32638.
32. Opie LH, Seedat KY. Hypertension in sub-Saharan African populations 2005. Circulation. 2005 Dec 6;112(23):3562-8.
33. Global Health Observatory Data Repository [Internet]. 2012. Available from: http://apps.who.int/ghodata/. Accessed 5th February 2013.
34. van de Vijver SJ, Oti SO, Agyemang C, Gomez GB, Kyobutungi C. Prevalence, awareness, treatment and control of hypertension among slum dwellers in Nairobi, Kenya. J Hypertens. 2013 May;31(5):1018-24.
35. Rodgers A, Ezzati M, Vander Hoorn S, Lopez AD, et al. Distribution of major health risks: findings from the Global Burden of Disease study. PLoS medicine. 2004 Oct;1(1):e27.
36. Beaglehole R, Bonita R, Horton R, Adams C, et al. Priority actions for the non-communicable disease crisis. The Lancet. 2011;377(9775):1438-47.
37. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL. Selected major risk factors and global and regional burden of disease. The Lancet. 2002;360(9343):1347-60.
38. Lawoyin TO, Asuzu MC, Kaufman J, Rotimi C, Owoaje E, Johnson L, et al. Prevalence of cardiovascular risk factors in an African, urban inner city community. West African journal of medicine. 2002 Jul-Sep;21(3):208-11.
39. McBride P, Einerson J, Hanson P, Heindel K. Exercise and the primary prevention of coronary heart disease. Medicine, Exercise, Nutrition and Health 1992; 1: 5-15. r
40. Haskell WL, Leon AS, Caspersen CJ. Cardiovascular benefits and assessment of physical activity and physical fitness in adults. Med Sci Sports Exerc. 1992 Jun;24(6 Suppl):S201-20.
41. Gersh BJ, Sliwa K, Mayosi BM, Yusuf S. Novel therapeutic conceptsThe epidemic of cardiovascular disease in the developing world: global implications. European Heart Journal. 2010 March 1, 2010;31(6):642-8.
42. Cappuccio FP, Sally MK, Frank BM, Jacob P-R, John BE. A community programme to reduce salt intake and blood pressure in Ghana. BMC Public Health. 2006 Jan 24;6:13.
43. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction. BMJ. 1991 Apr 6;302(6780):819-24.
44. Mtabaji JP, Nara YM, Mano MM, Yamori Y. Ethnic differences in salt sensitivity: Genetic or environmental factors. Clin Exp Pharmacol Physiol Suppl. 1992;20:65-7.
45. Obel AO, Koech DK. Potassium supplementation versus bendrofluazide in mildly to moderately hypertensive Kenyans. J Cardiovasc Pharmacol. 1991 March;3(17):504-7.
46. Ness AR, Powles JW. Fruit and vegetables, and cardiovascular disease: A review. Int J Epidemiol. 1997 Feb;26(1):1-13.
47. Popkin BM. Global nutrition dynamics: The world is shifting rapidly toward a diet linked with non-communicable diseases. Am J Clin Nutr. 2006 Aug;84(2):289-98.
48. Obesity: Preventing and managing the global epidemic. WHO Technical report series 894. Geneva: World Health Organization, 2000. r
49. de-Graft Aikins A, Unwin N, Agyemang C, Allotey P, et al. Tackling Africa's chronic disease burden: From the local to the global. Global Health. 2010 Apr 19;6:5.
50. van de Vijver S, Oti S, Addo J, de Graft-Aikins A, Agyemang C. Review of community-based interventions for prevention of cardiovascular diseases in low-and middle-income countries. Ethn Health. 2012;17(6):651-76.
51. Hendriks M, Brewster L, Wit F, Bolarinwa O, et al. Cardiovascular disease prevention in rural Nigeria in the context of a community based health insurance scheme: QUality Improvement Cardiovascular care Kwara-I (QUICK-I). BMC Public Health. 2011;11(1):186.
52. Kengne AP, Awah PK, Fezeu LL, Sobngwi E, Mbanya JC. Primary health care for hypertension by nurses in rural and urban sub-Saharan Africa. Journal of clinical hypertension (Greenwich, Conn). 2009 Oct;11(10):564-72.
53. Whelton PK, Beevers DG, Sonkodi S. Strategies for improvement of awareness, treatment and control of hypertension: Results of a panel discussion. J Hum Hypertens. 2004 Aug;18(8):563-5.
54. Ben Romdhane H, Ben Ali S, Skhiri H, Traissac P, Bougatef S, Maire B, et al. Hypertension among Tunisian adults: results of the TAHINA project. Hypertens Res. 2012 Mar;35(3):341-7.
55. Ibrahim MM, Rizk H, Appel LJ, el Aroussy W, et al. Hypertension prevalence, awareness, treatment, and control in Egypt-Results from the Egyptian national Hypertension Project (NHP). Hypertension. 1995;26(6):886-90.
56. Twagirumukiza M, Jan DM, Thierry C, Robert VS, Luc VB. The use of antihypertensive medicines in primary health care settings. Antihypertensive drugs. 2010;8:131-52.
57. Twagirumukiza M, Van Bortel LM. Management of hypertension at the community level in sub-Saharan Africa (SSA): towards a rational use of available resources. J Hum Hypertens. 2011 Jan;25(1):47-56.
58. Elliott WJ. The costs of treating hypertension: What are the long-term realities of cost containment and pharmacoeconomics. Postgrad Med. 1996 Apr;99(4):241-8, 251-2.
59. Guidelines for the management of hypertension at primary health care level. Hypertension Society of Southern Africa, endorsed by the Medical Association of South Africa and the Medical Research Council. S Afr Med J. 1995 Dec;85(12 Pt 2):1321-5.
60. WHO. Prevention of Cardiovascular Disease. Pocket Guidelines for Assessment and Management of Cardiovascular Risk. Geneva: World Health Organization, 2007.
61. WHO. The World Health Report 2002. 2002. http://www.who.int/whr/2002/en/whr02_en.pdf. Accessed 5th February 2013.
62. Smith R. Why a macroeconomic perspective is critical to the prevention of noncommunicable disease. Science. 2012 Sep 21;337(6101):1501-3.
63. Stewart S, Sliwa K. Preventing CVD in resource-poor areas: perspectives from the 'real-world'. Nature reviews Cardiology. 2009 Jul;6(7):489-92.
64. Miranda JJ, Kinra S, Casas JP, Davey Smith G, Ebrahim S. Non-communicable diseases in low-and middle-income countries: context, determinants and health policy. Tropical Medicine & International Health. 2008;13(10):1225-34.
65. Sung SY, Vicki BR, Tatiana L, Margaret DC. Publications and information products. Hypertension among adults in the United States 2009-2010: Centers for Disease Control and Prevention. http://www.cdc.gov/nchs/data/databriefs/db107.htm. Accessed 5th February 2013.
66. Lemogoum D, Seedat YK, Mabadeje AF, Mendis S, et al. Recommendations for prevention, diagnosis and management of hypertension and cardiovascular risk factors in sub-Saharan Africa. J Hypertens. 2003 Nov;21(11):1993-2000.
67. Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. The Lancet. 2008;371(9616):923-31.
68. Gaziano TA, Galea G, Reddy KS. Scaling up interventions for chronic disease prevention: the evidence. The Lancet. 2007;370(9603):1939-46.
69. Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens. 2009 May;27(5):963-75.
70. United Nations. Political declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. United Nations, 2011. r
71. Steven VDV, Samuel OO, Agyemang C, Gabriela B, Kyobutungi C. Prevalence, awareness, treatment and control of hypertension with associated factors among adults in slums of Nairobi, Kenya. Masters Thesis. 2010.
72. WHO. Global Atlas on cardiovascular disease prevention and control. 2011. Geneva: WHO.